Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Ann N Y Acad Sci. 2009 Jan;1152:174–186. doi: 10.1111/j.1749-6632.2008.03994.x

FIGURE 5.

FIGURE 5

Agonist-mediated inhibition of basal PRL release in pituitary cells with forskolin-induced elevation of cAMP production. (A) Effects of forskolin and apomorphine on cAMP (top) and PRL (bottom) release. (B) Effects of forskolin and ET-1 on cAMP (top) and PRL (bottom) release. Horizontal bars indicate duration of forskolin treatment and gray areas represent duration of GPCR agonist application. Open circles, cells treated with agonists only.